Nonmalignant hyperthermia and malignant hyperthermia confused.
Nonmalignant hyperthermia and malignant hyperthermia confused.
复制标题
非恶性高热与恶性高热混淆。
DOI:
10.1016/j.jclinane.2008.01.005
复制
发表时间:
2008
影响因子:
6.7
通讯作者:
Miller,Jordan
中科院分区:
文献类型:
--
作者:
Parness,Jerome;Herlich,Andrew;Torp,KlausD;Larach,MarilynG;Miller,Jordan
This letter is in response to the recent case report,“Malignant hyperthermia associated with diabetic hyperosmolar hyperglycemic nonketotic state in a young man”, by Amir R. Baluch and Sanjay P. Oommen [1]. We question the declarative use of the term “malignant hyperthermia” in the title, rather than the less certain, and more appropriate, term “malignant hyperthermia-like syndrome”, as used in Reference 1 of the report. There are no pathognomonic signs of MH, and a number of different pathophysiological states may mimic MH. Indeed, this journal published such a case entitled “Nonmalignant hyperthermia on induction of anesthesia in a pediatric patient undergoing bi-directional Glenn procedure”[2]. The only definitive tests for MH available at present are a genetic test for known causative mutations in the skeletal muscle intracellular Ca2+ release channel, the type 1 ryanodine receptor (RYR1)(see www. emhg. org for a list of these mutations), or, in North America, a live muscle biopsy specimen subjected to a caffeine-halothane contracture test [3]. Unfortunately, the patient expired, and no post-mortem material was reported to have been sent for genetic testing. Had the authors successfully treated the patient’s fever with dantrolene, the assignment of MH as the cause might be more tenable [4]. However, dantrolene has been reported both to ameliorate the effects of sepsis [5] and act as an antipyretic [6, 7], so that